{"DataElement":{"publicId":"13474632","version":"1","preferredName":"Lung Adenocarcinoma In Situ Percent Lepidic Growth Pattern Percent Number","preferredDefinition":"The percentage of the lung cancer tissue sample that exhibits a lepidic growth pattern.","longName":"PercentLepidic","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"13472815","version":"1","preferredName":"Lung Adenocarcinoma In Situ Percent Lepidic Growth Pattern","preferredDefinition":"A localized non-invasive adenocarcinoma of the lung measuring 3 cm or less. It is characterized by a pure lepidic growth pattern and the lack of stromal, vascular, or pleural invasion.:A morphologic finding indicating that the neoplastic cells have proliferated along the surface of intact alveoli without stromal or vascular invasion.","longName":"13472813v1.00:13472814v1.00","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"13472813","version":"1","preferredName":"Lung Adenocarcinoma In Situ","preferredDefinition":"A localized non-invasive adenocarcinoma of the lung measuring 3 cm or less. It is characterized by a pure lepidic growth pattern and the lack of stromal, vascular, or pleural invasion.","longName":"C136486","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Adenocarcinoma In Situ","conceptCode":"C136486","definition":"A localized non-invasive adenocarcinoma of the lung measuring 3 cm or less. It is characterized by a pure lepidic growth pattern and the lack of stromal, vascular, or pleural invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FAA66EFC-E103-6EE6-E053-731AD00AC07F","latestVersionIndicator":"Yes","beginDate":"2023-05-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-01","modifiedBy":"GDEEN","dateModified":"2023-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"13472814","version":"1","preferredName":"Lepidic Growth Pattern","preferredDefinition":"A morphologic finding indicating that the neoplastic cells have proliferated along the surface of intact alveoli without stromal or vascular invasion.","longName":"C55821","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lepidic Growth Pattern","conceptCode":"C55821","definition":"A morphologic finding indicating that the neoplastic cells have proliferated along the surface of intact alveoli without stromal or vascular invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FAA66EFC-E104-6EE6-E053-731AD00AC07F","latestVersionIndicator":"Yes","beginDate":"2023-05-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-01","modifiedBy":"GDEEN","dateModified":"2023-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FAA66EFC-E10B-6EE6-E053-731AD00AC07F","latestVersionIndicator":"Yes","beginDate":"2023-05-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-01","modifiedBy":"GDEEN","dateModified":"2023-05-15","changeDescription":null,"administrativeNotes":"05.15.23_Curated to support MILD_ghd","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2475074","version":"1","preferredName":"Percent Number","preferredDefinition":"Numeric value representing a percentage.","longName":"PCT_NUM","context":"CCR","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":null,"maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":"1","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2475073","version":"1","preferredName":"Percent Number","preferredDefinition":"LITERAL:Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.","longName":"C48570:C25337","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percent Unit","conceptCode":"C48570","definition":"A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11828C54-12CD-5D08-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-15","modifiedBy":"ONEDATA","dateModified":"2006-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11828C54-12DE-5D08-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-15","modifiedBy":"GDEEN","dateModified":"2023-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3533741","version":"1","longName":"NCORP (NCI Community Oncology Research Program","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3533742","version":"1","longName":"Screening and Accrual Log","context":"NCIP"}]},{"publicId":"6705584","version":"1","longName":"CCG PTCL (Center for Cancer Genomics - Peripheral T Cell Lymphoma)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"13461199","version":"1","longName":"MILD","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Percent of lepidic/in situ component in ADC","type":"Preferred Question Text","description":"Percent of lepidic/in situ component in ADC","url":null,"context":"NCIP"}],"origin":"CCG:Center for Cancer Genomics","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FAAC61FE-09F6-7BC2-E053-731AD00A8A3F","latestVersionIndicator":"Yes","beginDate":"2023-05-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-01","modifiedBy":"GDEEN","dateModified":"2023-05-15","changeDescription":null,"administrativeNotes":"05.15.23_Curated to support MILD_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}